Rare FIG names make use of vaccine booster

Covid_vaccine_575px_Adobe_26June20
By Frank Jackman
17 Nov 2020

A pair of smaller names were tempted into the euro market on Tuesday, after Monday’s news that scientists have developed another successful vaccine for Covid-19 led to a further improvement of market conditions.

US biotech company Moderna said on Monday that its coronavirus vaccine was about 95% effective in clinical trials.

Its statement followed a similar announcement last week from Pfizer and BioNTech, which have also developed a vaccine that is more than 90% efficient. 

The news main driver for a bounce ...

Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free trial